Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00717418 · ClinicalTrials.gov registry record
Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 781
- Enrollment target
NCT00717418 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 781 participants.
The verdict
NCT00717418 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 781 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy of cyclosporine ophthalmic solution vs. other non-prescription treatments in patients with dry eye disease. Patient and physician assessments completed at baseline, at each follow-up visit (follow-up visits are variable as per physician discretion) and at final follow-up visit.
Interventions
- DRUG cyclosporine ophthalmic emulsion 0.05%, artificial tears
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 781 participants |
| Start Date | 2004-09 |
| Est. Completion | 2008-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00717418
The ClinicalTrials.gov registry entry for NCT00717418 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 781 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cyclosporine ophthalmic emulsion 0.05%, artificial tears is the first listed.
NCT00717418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00717418 about?
NCT00717418 is a clinical study titled "Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease". This study will evaluate the efficacy of cyclosporine ophthalmic solution vs. other non-prescription treatments in patients with dry eye disease. Patient and physician assessments completed at baseline, at each follow-up visit (follow-up visits are variable as per physician discretion) and at final ...
What is the current status of trial NCT00717418?
This trial is currently completed. The enrollment target is 781 participants. The study started on 2004-09. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00717418?
The interventions under investigation include: cyclosporine ophthalmic emulsion 0.05%, artificial tears (DRUG).
Who is sponsoring clinical trial NCT00717418?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.